Human medicines European public assessment report (EPAR): Prevenar 20 (previously Apexxnar), pneumococcal polysaccharide conjugate ...
Studies in adults In 2 main studies, Prevenar 20 was shown to trigger immune responses that were comparable to those triggered by two other authorised pneumococcal vaccines (Prevenar 13, a vaccine that protects against 13 types of S. pneumoniae; Pneumovax …